These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29128260)

  • 1. Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology.
    Cases A; Egocheaga MI; Tranche S; Pallarés V; Ojeda R; Górriz JL; Portolés JM
    Nefrologia (Engl Ed); 2018; 38(1):8-12. PubMed ID: 29128260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology].
    Cases A; Egocheaga MI; Tranche S; Pallarés V; Ojeda R; Górriz JL; Portolés JM
    Aten Primaria; 2018 Jan; 50(1):60-64. PubMed ID: 29224999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology].
    Cases A; Egocheaga MI; Tranche S; Pallarés V; Ojeda R; Górriz JL; Portolés JM
    Semergen; 2018; 44(1):37-41. PubMed ID: 29229312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal anemia: current treatments and emerging molecules.
    Heras-Benito M
    Rev Clin Esp (Barc); 2023; 223(7):433-439. PubMed ID: 37348652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrology referral slows the progression of chronic kidney disease, especially among patients with anaemia, diabetes mellitus, or hypoalbuminemia: A single-centre, retrospective cohort study.
    Ide A; Ota K; Murashima M; Suzuki K; Kasugai T; Miyaguchi Y; Tomonari T; Ono M; Mizuno M; Hiratsuka M; Kawai T; Suzuki T; Murakami K; Hamano T
    Nephrology (Carlton); 2024 Aug; 29(8):510-518. PubMed ID: 38692707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and treatment of renal anaemia in Spain: RIKAS retrospective study.
    Cases A; Sánchez EGA; Cadeddu G; Lorenzo MM
    Nefrologia (Engl Ed); 2023; 43(5):562-574. PubMed ID: 37914638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaemia, diabetes and chronic kidney disease: where are we now?
    Stevens PE
    J Ren Care; 2012 Feb; 38 Suppl 1():67-77. PubMed ID: 22348366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study.
    Martínez-Castelao A; Cases A; Carballada AT; Iranzo JT; Bronsoms J; Vallès-Prats M; Monserrat DT; Jimenez EM;
    Nefrologia; 2015; 35(2):179-88. PubMed ID: 26300512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythropoietin stimulating agents in chronic kidney disease: indications and contraindications].
    Żebrowski P; Mieczkowski M
    Wiad Lek; 2016; 69(5):753-755. PubMed ID: 28033602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anaemia control model: Does it help nephrologists in therapeutic decision-making in the management of anaemia?
    Bucalo ML; Barbieri C; Roca S; Ion Titapiccolo J; Ros Romero MS; Ramos R; Albaladejo M; Manzano D; Mari F; Molina M
    Nefrologia (Engl Ed); 2018; 38(5):491-502. PubMed ID: 29875061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer.
    Hazzan AD; Shah HH; Hong S; Sakhiya V; Wanchoo R; Fishbane S
    Kidney Int; 2014 Jul; 86(1):34-9. PubMed ID: 24402094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unresolved aspects in the management of renal anemia, a Delphi consensus of the Anemia Group of the S.E.N.
    Portolés J; Martín-Malo A; Martín-Rodríguez L; Fernández-Fresnedo G; De Sequera P; Emilio Sánchez J; Ortiz-Arduan A; Cases A;
    Nefrologia (Engl Ed); 2023; 43(5):517-530. PubMed ID: 37993379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New expectations in the treatment of anemia in chronic kidney disease.
    López-Gómez JM; Abad S; Vega A
    Nefrologia; 2016; 36(3):232-6. PubMed ID: 27137103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease, anemia, and epoetin.
    Riley DS
    N Engl J Med; 2007 Mar; 356(9):956; author reply 958-9. PubMed ID: 17329706
    [No Abstract]   [Full Text] [Related]  

  • 15. International treatment guidelines for anaemia in chronic kidney disease - what has changed?
    Macginley RJ; Walker RG
    Med J Aust; 2013 Jul; 199(2):84-5. PubMed ID: 23879487
    [No Abstract]   [Full Text] [Related]  

  • 16. Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines.
    Hung SC; Kuo KL; Tarng DC; Hsu CC; Wu MS; Huang TP
    Nephrology (Carlton); 2014 Dec; 19(12):735-9. PubMed ID: 25156587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure in patients with kidney disease and iron deficiency; the role of iron therapy.
    Cases Amenós A; Ojeda López R; Portolés Pérez JM;
    Nefrologia; 2017; 37(6):587-591. PubMed ID: 28610806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Masters of Erythropoiesis: Hypoxia Inducible Factors and Recent Advances in Anemia of Renal Disease.
    Solak Y; Cetiner M; Siriopol D; Tarim K; Afsar B; Covic A; Kanbay M
    Blood Purif; 2016; 42(2):160-7. PubMed ID: 27318465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of anemia in CKD.
    Babitt JL; Lin HY
    J Am Soc Nephrol; 2012 Oct; 23(10):1631-4. PubMed ID: 22935483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia in children with chronic kidney disease.
    Greenbaum LA
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):385-96. PubMed ID: 16198278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.